151 related articles for article (PubMed ID: 9769129)
1. Cell-type- and tumour-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours.
Miettinen M; Sarlomo-Rikala M; Kovatich AJ
Virchows Arch; 1998 Sep; 433(3):255-60. PubMed ID: 9769129
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.
Suster S; Fisher C; Moran CA
Am J Surg Pathol; 1998 Jul; 22(7):863-72. PubMed ID: 9669348
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 expression in pleural and extrapleural solitary fibrous tumours.
Chilosi M; Facchettti F; Dei Tos AP; Lestani M; Morassi ML; Martignoni G; Sorio C; Benedetti A; Morelli L; Doglioni C; Barberis M; Menestrina F; Viale G
J Pathol; 1997 Apr; 181(4):362-7. PubMed ID: 9196431
[TBL] [Abstract][Full Text] [Related]
4. BCL-6 expression in mesenchymal tumours: an immunohistochemical and fluorescence in situ hybridisation study.
Walters MP; McPhail ED; Law ME; Folpe AL
J Clin Pathol; 2011 Oct; 64(10):866-9. PubMed ID: 21725042
[TBL] [Abstract][Full Text] [Related]
5. The role of cytogenetics in the classification of soft tissue tumours.
Dei Tos AP; Dal Cin P
Virchows Arch; 1997 Aug; 431(2):83-94. PubMed ID: 9293889
[TBL] [Abstract][Full Text] [Related]
6. Neural cell adhesion molecule distribution in soft tissue tumors.
Miettinen M; Cupo W
Hum Pathol; 1993 Jan; 24(1):62-6. PubMed ID: 7678094
[TBL] [Abstract][Full Text] [Related]
7. bcl-2 is preferentially expressed in tumours of muscle origin but is not related to p53 expression.
Soini Y; Pääkkö P
Histopathology; 1996 Feb; 28(2):141-5. PubMed ID: 8834522
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization.
Hirakawa N; Naka T; Yamamoto I; Fukuda T; Tsuneyoshi M
Hum Pathol; 1996 Oct; 27(10):1060-5. PubMed ID: 8892591
[TBL] [Abstract][Full Text] [Related]
9. Solitary fibrous tumour of the pancreas: a new member of the small group of mesenchymal pancreatic tumours.
Lüttges J; Mentzel T; Hübner G; Klöppel G
Virchows Arch; 1999 Jul; 435(1):37-42. PubMed ID: 10431844
[TBL] [Abstract][Full Text] [Related]
10. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM
Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation.
Dickson BC; Riddle ND; Brooks JS; Pasha TL; Zhang PJ
Hum Pathol; 2013 Jun; 44(6):1125-30. PubMed ID: 23332867
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
[TBL] [Abstract][Full Text] [Related]
14. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.
Tallini G; Parham DM; Dias P; Cordon-Cardo C; Houghton PJ; Rosai J
Am J Pathol; 1994 Apr; 144(4):693-701. PubMed ID: 8160771
[TBL] [Abstract][Full Text] [Related]
15. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterisation of soft tissue tumours: a gene expression study.
Nielsen TO; West RB; Linn SC; Alter O; Knowling MA; O'Connell JX; Zhu S; Fero M; Sherlock G; Pollack JR; Brown PO; Botstein D; van de Rijn M
Lancet; 2002 Apr; 359(9314):1301-7. PubMed ID: 11965276
[TBL] [Abstract][Full Text] [Related]
17. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
18. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours.
Soini Y; Vähäkangas K; Nuorva K; Kamel D; Lane DP; Pääkkö P
J Pathol; 1992 Sep; 168(1):29-33. PubMed ID: 1333524
[TBL] [Abstract][Full Text] [Related]
19. Frequent expression of bcl-2 protein in solitary fibrous tumors.
Hasegawa T; Matsuno Y; Shimoda T; Hirohashi S; Hirose T; Sano T
Jpn J Clin Oncol; 1998 Feb; 28(2):86-91. PubMed ID: 9544821
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): a study of 143 benign and malignant soft tissue and bone tumours.
Patel RM; Folpe AL
Pathology; 2009; 41(6):527-32. PubMed ID: 19900100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
